Literature DB >> 8077936

Oral-oesophageal inoculation of mice with herpes simplex virus type 1 causes latent infection of the vagal sensory ganglia (nodose ganglia).

R M Gesser1, T Valyi-Nagy, S M Altschuler, N W Fraser.   

Abstract

Herpes simplex virus type 1 (HSV-1) gingivostomatitis during childhood is known to result in a latent infection of the trigeminal ganglion neurons, which innervate the oral mucosa. During latency the viral genome is maintained in a non-infectious state. However, stimuli such as stress, fever or localized trauma can cause HSV-1 to reactivate in neurons and produce recrudescent disease in the peripheral tissues. Recently, HSV-1 proteins and nucleic acids have been detected in biopsies from human duodenal and gastric ulcers, raising the possibility that HSV-1 latency within the enteric nervous system is involved in this chronic recurrent gastrointestinal disorder. The studies in mice described here were done to determine whether HSV-1 latency could be established in neurons that innervate the murine gut. We found that after either intraperitoneal or oral-oesophageal inoculation of mice, HSV-1 establishes a latent infection in nodose ganglia of the vagus nerve, whose sensory neurons project to the gastrointestinal tract. This animal model of HSV-1 latency in the vagal sensory ganglia will be useful to examine the possible relationship between HSV-1 and recurrent gastrointestinal disease.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8077936     DOI: 10.1099/0022-1317-75-9-2379

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  11 in total

Review 1.  Experimental investigation of herpes simplex virus latency.

Authors:  E K Wagner; D C Bloom
Journal:  Clin Microbiol Rev       Date:  1997-07       Impact factor: 26.132

2.  Replication of herpes simplex virus type 1 and 2 in the medulla of the adrenal gland after vaginal infection of mice.

Authors:  J Podlech; F Hengerer; M Fleck; I Walev; D Falke
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

3.  Effect of apolipoprotein E on the cerebral load of latent herpes simplex virus type 1 DNA.

Authors:  Javier S Burgos; Carlos Ramirez; Isabel Sastre; Fernando Valdivieso
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

4.  Latent herpes simplex virus type 1 gene expression in ganglia innervating the human gastrointestinal tract.

Authors:  R M Gesser; S C Koo
Journal:  J Virol       Date:  1997-05       Impact factor: 5.103

5.  Oral inoculation with herpes simplex virus type 1 infects enteric neuron and mucosal nerve fibers within the gastrointestinal tract in mice.

Authors:  R M Gesser; S C Koo
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

6.  Adenosine-mediated enteric neuromuscular function is affected during herpes simplex virus type 1 infection of rat enteric nervous system.

Authors:  Chiara Zoppellaro; Anna Bin; Paola Brun; Serena Banzato; Veronica Macchi; Ignazio Castagliuolo; Maria Cecilia Giron
Journal:  PLoS One       Date:  2013-08-27       Impact factor: 3.240

7.  Herpes simplex virus 1 targets the murine olfactory neuroepithelium for host entry.

Authors:  Maitreyi Shivkumar; Ricardo Milho; Janet S May; Michael P Nicoll; Stacey Efstathiou; Philip G Stevenson
Journal:  J Virol       Date:  2013-07-31       Impact factor: 5.103

8.  Unilateral Vocal Cord Paralysis of a Great Jewish Opera Singer.

Authors:  Irit Duek; Jacob T Cohen; Ziv Gil
Journal:  Rambam Maimonides Med J       Date:  2018-01-29

9.  Viral Spread to Enteric Neurons Links Genital HSV-1 Infection to Toxic Megacolon and Lethality.

Authors:  William Khoury-Hanold; Brian Yordy; Philip Kong; Yong Kong; William Ge; Klara Szigeti-Buck; Alexandra Ralevski; Tamas L Horvath; Akiko Iwasaki
Journal:  Cell Host Microbe       Date:  2016-06-08       Impact factor: 21.023

Review 10.  Tumor-related dysmotility: gastrointestinal dysmotility syndromes associated with tumors.

Authors:  J K DiBaise; E M Quigley
Journal:  Dig Dis Sci       Date:  1998-07       Impact factor: 3.487

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.